ASHG 2026 has ended. This guide stays up as the record of who was there. Next: ASHG 2027, Oct 26–30, 2027 in Nashville
23andMe at ASHG 2026
Oct 20–24, 2026 Montréal, Canada ~7.5k attendees Website
23andMe brings 3 presentations to ASHG 2026 in Montréal, and exhibits at Booth 400. Its program at this meeting centres on cancer, population genetics, and clinical genetics. Its presentations cover rare-variant burden testing, validating self-reported traits in a genotyped cohort, and medically actionable results from direct-to-consumer testing.
| Organization | ASHG 2026 Attendance |
|---|---|
23andMe Palo Alto, California | 1 Senior Scientist · 1 Vice President of Genomic Health and Chief Medical Officer · 1 Applied Scientist |
23andMe sells consumer genetic testing, ancestry reports, and health memberships. It provides genomic data, research services, and participant recruitment to biopharma partners.
| Booth Exhibiting at Booth 400 · 23andMe Research Institute Wed, Oct 219:30am–4:30pmThu, Oct 229:30am–6:15pmFri, Oct 239:30am–4:30pm Session Thu Oct 22 5:00 pm Poster Thu Oct 22 4:15 pm Genome-wide burden testing of imputed rare variants recovers sequencing-based signals Rare variantsComplex traits Poster Thu Oct 22 4:15 pm Validation of self-reported phenotypes in a real world genotyped cohort Electronic health recordsPhenotypeClinical historyDatabases Talk Fri Oct 23 1:45 pm One in ten individuals receives a medically actionable result through direct-to-consumer genetic testing: Insights from 6 million research participants EpidemiologyGenetic testingLarge-scale biobanksPrecision medicine |
Find decision makers at 23andMe
Tell us what you sell and we’ll find the people at 23andMe most likely to buy it.
- Who to contact
- Their contact info
- What to say
- Free, no sign-up
Not affiliated with or endorsed by the American Society of Human Genetics. Submit a correction